Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Packer

Showing results (21-30 of 326) with videos related to

Pageof 33
Sort By:
The American Journal of Cardiology|January 25, 1985
Therapeutic application of calcium-channel antagonists for pulmonary hypertensionM Packer
Journal of Cardiovascular Pharmacology|January 1, 1989
Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonistsM Packer
The New England Journal of Medicine|June 4, 1987
Do vasodilators prolong life in heart failure?M Packer
Journal of the American College of Cardiology|November 1, 1989
Second generation calcium channel blockers in the treatment of chronic heart failure: are they any better than their predecessors?M Packer
The American Journal of Cardiology|March 6, 1990
Hormone-electrolyte interactions in congestive heart failure: lessons from a 4,000-year-old Sumerian tabletM Packer
Chest|October 1, 1985
Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapyM Packer
Circulation|September 15, 1995
Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?M Packer
Circulation|August 1, 1990
Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failureM Packer
Lancet (London, England)|July 11, 1992
Treatment of chronic heart failureM Packer
Journal of the American College of Cardiology|July 1, 1992
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failureM Packer
Pageof 33

Showing results (21-30 of 326) with videos related to

Sort By:
Pageof 33
The American Journal of Cardiology|January 25, 1985
Therapeutic application of calcium-channel antagonists for pulmonary hypertensionM Packer
Journal of Cardiovascular Pharmacology|January 1, 1989
Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonistsM Packer
The New England Journal of Medicine|June 4, 1987
Do vasodilators prolong life in heart failure?M Packer
Journal of the American College of Cardiology|November 1, 1989
Second generation calcium channel blockers in the treatment of chronic heart failure: are they any better than their predecessors?M Packer
The American Journal of Cardiology|March 6, 1990
Hormone-electrolyte interactions in congestive heart failure: lessons from a 4,000-year-old Sumerian tabletM Packer
Chest|October 1, 1985
Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapyM Packer
Circulation|September 15, 1995
Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?M Packer
Circulation|August 1, 1990
Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failureM Packer
Lancet (London, England)|July 11, 1992
Treatment of chronic heart failureM Packer
Journal of the American College of Cardiology|July 1, 1992
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failureM Packer
Pageof 33